Search

Your search keyword '"Jean Marie F. Damorou"' showing total 4 results
Start Over Author "Jean Marie F. Damorou"
4 results on '"Jean Marie F. Damorou"'

1. Antihypertensive strategies and hypertension control in Sub-Saharan Africa

Author

Abdallahi Sidy Ali, Méo Stéphane Ikama, Murielle Hounkponou, Anastase Dzudie, Gabriel S. Tajeu, Jean Marie F. Damorou, Jean Laurent Takombe, Emmanuel Limbole, Ibrahim Ali Toure, Suzy Gisèle Kimbally-Kaki, Adama Kane, Xavier Jouven, Michel Azizi, Carol Nhavoto, Liliane Mfeukeu Kuate, Kouadio Euloge Kramoh, Samuel Kingue, Dadhi M. Balde, Martin Dèdonougbo Houenassi, Charles Kouam Kouam, Marie Antignac, Jean Bruno Mipinda, Beatriz Ferreira, Roland N'Guetta, Bamba Gaye, Ibrahima Bara Diop, Marie Cécile Perier, Diane Macquart de Terline, Pauline Cavagna, Pôle de Pharmacie - Santé Publique - Information médicale [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), University Marien Ngouabi of Brazzaville (umng), Institute of Cardiology of Abidjan [Abidjan, Côte d’Ivoire], Ngaliema Hospital [Kinshasa, Democratic Republic of the Congo], University Hospital of Fann [Dakar, Senegal], University Hospital of Lamorde [Niamey, Niger], Department of Cardiology [Conakry, Guinea], University Hospital of Conakry [Conakry, Guinea], Douala General Hospital, Internal Medicine Department, Douala, Cameroun, Instituto do Coração [Maputo, Mozambique] (ICOR), National University hospital of Hubert K. MAGA [Cotonou, Bénin] (CNHU-HKM), Hôpital Aristide-Le-Dantec, University of Yaoundé [Cameroun], Régional Hospital [Bafoussam, Cameroon], University of Kinshasa (UNIKIN), University hospital of Libreville [Libreville, Gabon], Université de Lomé [Togo], Faculté des Sciences et Techniques [Nouakchott, Mauritania], Temple University [Philadelphia], Pennsylvania Commonwealth System of Higher Education (PCSHE), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), HAL-SU, Gestionnaire, Pôle de Pharmacie - Santé Publique - Information médicale [Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), and Faculty of Medicine, University of Kinshasa

Subjects
Sub saharan, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Hypertension control, Epidemiology, business.industry, MEDLINE, developing countries, 030204 cardiovascular system & hematology, Article, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Environmental health, cardiology, Hypertension, Humans, Medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Africa South of the Sahara, Antihypertensive Agents, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, antihypertensive medications
Abstract

International audience

Published
2020
Full Text
View/download PDF

2. Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies

Author

Roland N'Guetta, Yessoufou Tchabi, Louise Boyer Chatenet, Eloi Marijon, Jean Laurent Takombe, Marie Antignac, Jean Philippe Empana, Ibrahim Ali Toure, Méo Stéphane Ikama, Mélisande Bernard, Dadhi M. Balde, Jean Marie F. Damorou, Bernard Do, Abdallahi Sidi Aly, Xavier Jouven, Kumar Narayanan, Ibrahima Bara Diop, Diane Macquart de Terline, Patrick Zabsonre, Service de Pharmacie [CHU Saint Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Agence Générale des Equipements et Produits de Santé [Paris] (AGEPS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris-Sud - Paris 11 (UP11), University Marien Ngouabi of Brazzaville (umng), Service de cardiologie [CHU HEGP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)

Subjects
business.industry, Health Policy, Substandard Drugs, [SDV]Life Sciences [q-bio], Public Health, Environmental and Occupational Health, Cardiovascular Agents, 030204 cardiovascular system & hematology, 3. Good health, Viewpoints, 03 medical and health sciences, 0302 clinical medicine, Consumer Product Safety, Counterfeit Drugs, Africa, Medicine, Humans, 030212 general & internal medicine, business, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience

Published
2019
Full Text
View/download PDF

3. P3344Research network in Africa (RNA): observatory of hospitalizations in cardiology departments in 14 African countries (FEBRUARY Study: 2016, 2017 and 2018)

Author

Jean Philippe Empana, A Sidy Ali, Jean Marie F. Damorou, C Kouam Kouam, N Jolis, Ibrahima Bara Diop, Stéphane Méo Ikama, A.A. Suliman, Xavier Jouven, D Balde, Samuel Kingue, Marie Antignac, A Niakara, Ibrahim Ali Toure, and Amadou Traoré

Subjects
medicine.medical_specialty, Observatory, business.industry, Family medicine, medicine, Cardiology departments, Cardiology and Cardiovascular Medicine, business
Abstract

Background Epidemiological transition in the developing world has resulted in a shift from infectious to non-communicable diseases as leading causes of morbidity and mortality, cardiovascular (CV) disease (CVD) is the first cause of death in Africa. However, data regarding the characteristic of patients with CVD are scarce, especially in Sub-Saharan Africa. Purpose We built an observatory recording the characteristics of all patients admitted to hospital in CV departments and hospital care components in Sub-Saharan Africa (FEBRUARY Study). Methods We conducted a transversal and longitudinal study in CV departments of 29 hospitals from 14 African countries. FEBRUARY study was designed by a multidisciplinary collaborative team of epidemiologists, pharmacists and cardiologists from Africa and France. This ongoing observatory included all patients admitted in hospitalization during the month of February every year since 2016 and will continue every year. Data including socio-demographic and clinical characteristics, causes of admission, clinical, biological, complementary examinations, treatments, length of stay and discharge diagnosis were collected by the investigating physicians. Results Overall 2680 patients were admitted to hospital in February 2016 (n=736), 2017 (n=967), and 2018 (n=987) in CV departments from 14 countries: Benin, Burkina Faso, Burundi, Cameroon, Congo, Côte d'Ivoire, Gabon, Guinea, Mali, Niger, Dem. Rep of The Congo, Senegal, Togo and Sudan (figure). Men represented 58,8%. Mean age of age was 54 years and Women 52 years. The mean length of stay was 9 days, and death rate 10,1%. The main cause of admission was cardiac failure (40,3%) followed by acute coronary syndrome (10.1%) and stroke (9,3%). Among CV risk factors, high blood pressure, sedentary behavior, diabetes, active tobacco consumption and dyslipidemia were present in 46%, 19%, 13%, 11% and 6% of patients, respectively. In a longitudinal analysis, hospital admission due coronary syndrome increased from 7% in 2016 to 10.5% in 2018 (p for trend = 0.03). Length of hospital stay and rate of hospital death remain stable. Hospitalizations by country (FEBRUARY) Conclusion The FEBRUARY observatory is an important tool to describe cardiovascular characteristics of patients in transversal analysis, but also the longitudinal evolution over the coming years in Sub-Saharan Africa.

Published
2019
Full Text
View/download PDF

4. Fighting fake medicines: First quality evaluation of cardiac drugs in Africa

Author

Marie Antignac, Muriel Tafflet, Jean Marie F. Damorou, Pierre-François Plouin, Xavier Jouven, Yessoufou Tchabi, B.I. Diop, Eloi Marijon, Jean Laurent Takombe, Stéphane Méo Ikama, Dadhi M. Balde, Jean Philippe Empana, Bernard Do, Ibrahim Ali Toure, Roland N'Guetta, Abdallahi Sidi Aly, Christine Fernandez, Mélisande Bernard, Kumar Narayanan, Patrick Zabsonre, and Diane Macquart de Terline

Subjects
Quality Control, Cardiac drugs, media_common.quotation_subject, Developing country, Pharmacy, Pilot Projects, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Tandem Mass Spectrometry, Environmental health, Health care, Medicine, Humans, Quality (business), 030212 general & internal medicine, Amlodipine, Prospective Studies, Africa South of the Sahara, media_common, Pharmacies, Chromatography, Reverse-Phase, business.industry, Cardiovascular Agents, Drug standards, Counterfeit Drugs, Africa, Cardiology and Cardiovascular Medicine, business, medicine.drug, Chromatography, Liquid
Abstract

Background The growing menace of poor quality and falsified drugs constitutes a major hazard, compromising healthcare and patient outcomes. Efforts to assess drug standards worldwide have almost exclusively focused on anti-microbial drugs; with no study to date on cardiovascular drugs. Our study aims to assess quality of seven routinely used cardiovascular medications (anticoagulants, antihypertensives and statins) in ten Sub-Saharan African countries. Methods Drugs were prospectively collected using standardized methods between 2012 and 2014 from licensed (random pharmacies) and unlicensed (street-markets) places of sale in Africa. We developed a validated reversed-phase liquid chromatography with tandem mass spectrometry method to accurately quantify the active ingredient in a certified public laboratory. Three quality categories were defined based on the ratio of the measured to the expected dosage of the active ingredient: A (good quality): 95% to 105%, B (low quality): 85 to 94.99% or 105.01 to 115%, C (very low quality): 115%. Results All expected medicines (n=3468 samples) were collected in Benin, Burkina-Faso, Congo-Brazzaville, the Democratic Republic of Congo, Guinea, Cote d'Ivoire, Mauritania, Niger, Togo and Senegal. Out of the 1530 samples randomly tested, poor quality (types B and C) was identified in 249 (16.3%) samples. The prevalence of poor quality was significantly increased in certain specific drugs (amlodipine 29% and captopril 26%), in generic versions (23%) and in drugs produced in Asia (35%). The proportion of poor quality reached 50% when drugs produced in Asia were sold in street-markets. Conclusion In this first study assessing the quality of cardiovascular drugs in Africa, we found a significant proportion of poor quality drugs. This requires continued monitoring strategies.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results